Incyte (INCY) analysis: strong risk-adjusted returns, 20% YoY Q3 2025 revenue growth, diversification beyond Jakafi, and fair ...

The Global Evidence in Medicine for Parkinson’s disease (GEM-PD) initiative was launched by C-Path to focus on closing the gender gap in PD research and care through a comprehensive approach that ...

In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.

Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

In a reminder of the money still on the table for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Imagine going to the hospital for a bacterial ear infection and hearing your doctor say, "We're out of options." It may sound ...

An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...